Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.18 USD | -1.44% | +6.19% | +44.39% |
May. 24 | Lantern Pharma Files $150 Million Mixed Shelf | MT |
May. 09 | Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024 |
Business Summary
Number of employees: 21
Managers
Managers | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
David Margrave
DFI | Director of Finance/CFO | 64 | 18-05-31 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Kishor Bhatia
CTO | Chief Tech/Sci/R&D Officer | 69 | 19-11-30 |
Ernest Kitt
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
Director/Board Member | 73 | 22-06-07 | |
Donald Keyser
CHM | Chairman | 71 | 17-12-31 |
Vijay Chandru
BRD | Director/Board Member | 70 | 19-09-30 |
Director/Board Member | 73 | 18-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,758,805 | 9,171,558 ( 85.25 %) | 0 | 85.25 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.39% | 67.46M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- LTRN Stock
- Company Lantern Pharma Inc.